47 related articles for article (PubMed ID: 23985689)
21. New scaffolds of natural origin as Integrase-LEDGF/p75 interaction inhibitors: virtual screening and activity assays.
De Luca L; Morreale F; Christ F; Debyser Z; Ferro S; Gitto R
Eur J Med Chem; 2013 Oct; 68():405-11. PubMed ID: 23994868
[TBL] [Abstract][Full Text] [Related]
22. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
[TBL] [Abstract][Full Text] [Related]
23. Discovery of novel 3-hydroxypicolinamides as selective inhibitors of HIV-1 integrase-LEDGF/p75 interaction.
Zhang FH; Debnath B; Xu ZL; Yang LM; Song LR; Zheng YT; Neamati N; Long YQ
Eur J Med Chem; 2017 Jan; 125():1051-1063. PubMed ID: 27810592
[TBL] [Abstract][Full Text] [Related]
24. Fragment hopping approach directed at design of HIV IN-LEDGF/p75 interaction inhibitors.
De Luca L; Ferro S; Morreale F; Christ F; Debyser Z; Chimirri A; Gitto R
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1002-9. PubMed ID: 22803661
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a novel 5-carbonyl-1H-imidazole-4-carboxamide class of inhibitors of the HIV-1 integrase-LEDGF/p75 interaction.
Serrao E; Xu ZL; Debnath B; Christ F; Debyser Z; Long YQ; Neamati N
Bioorg Med Chem; 2013 Oct; 21(19):5963-72. PubMed ID: 23985689
[TBL] [Abstract][Full Text] [Related]
26. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
Christ F; Debyser Z
Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75.
De Luca L; Ferro S; Morreale F; De Grazia S; Chimirri A
ChemMedChem; 2011 Jul; 6(7):1184-91. PubMed ID: 21506277
[TBL] [Abstract][Full Text] [Related]
28. Recent Advances in the Development of Small-Molecular Inhibitors Target HIV Integrase-LEDGF/p75 Interaction.
Zhao Y; Luo Z
Mini Rev Med Chem; 2015; 15(14):1195-208. PubMed ID: 26156421
[TBL] [Abstract][Full Text] [Related]
29. Virtual-screening targeting Human Immunodeficiency Virus type 1 integrase-lens epithelium-derived growth factor/p75 interaction for drug development.
Gu WG; Liu BN; Yuan JF
J Drug Target; 2015 Feb; 23(2):134-9. PubMed ID: 25230778
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the interaction between HIV-1 integrase and its cofactor LEDGF/p75: a promising approach in anti-retroviral therapy.
De Luca L; Ferro S; Morreale F; Chimirri A
Mini Rev Med Chem; 2011 Jul; 11(8):714-27. PubMed ID: 21651465
[TBL] [Abstract][Full Text] [Related]
31. [LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].
Chen WM; Liu XY
Yao Xue Xue Bao; 2009 Sep; 44(9):953-60. PubMed ID: 20055168
[TBL] [Abstract][Full Text] [Related]
32. On the cell biology of HIV integration from basic research to development of novel antiviral drugs.
Debyser Z; Christ F
Verh K Acad Geneeskd Belg; 2010; 72(5-6):219-37. PubMed ID: 21409951
[TBL] [Abstract][Full Text] [Related]
33. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
34. LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 - 2014).
Demeulemeester J; Chaltin P; Marchand A; De Maeyer M; Debyser Z; Christ F
Expert Opin Ther Pat; 2014 Jun; 24(6):609-32. PubMed ID: 24666332
[TBL] [Abstract][Full Text] [Related]
35. Rational design of LEDGINs as first allosteric integrase inhibitors for the treatment of HIV infection.
Desimmie BA; Demeulemeester J; Christ F; Debyser Z
Drug Discov Today Technol; 2013 Dec; 10(4):e517-22. PubMed ID: 24451643
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]